mri for assessment of valvular heart disease: promises and
TRANSCRIPT
![Page 1: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/1.jpg)
MRI for assessment of valvular heart disease:promises and pitfalls
Alberto Roghi, MDNoninvasive Cardiac Laboratories, CMR UnitDepartment of Cardiology and Cardiovascular surgeryNiguarda Ca’Granda Hospital, Milan, Italy
![Page 2: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/2.jpg)
MR comprehensive evaluation
• Morphology
• Function
• Flow velocity
• 3D Angiography
• Collateral pathologies CADDCMHCMMyocarditisAortic diseasesCongenital HD
![Page 3: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/3.jpg)
MORPHOLOGY AND FUNCTION
SSFP CINE MRI
Aortic Regurgitation
![Page 4: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/4.jpg)
VALVULAR MORPHOLOGY – SSFP CINE MRI
Area = 2.56 cm2RO = 0.41 cm2
Circulation 2009; 119: 468-478
![Page 5: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/5.jpg)
LV FUNCTION – SSFP CINE MRI
![Page 6: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/6.jpg)
– PHASE-CONTRAST CINE MRI – IN PLANE
AORTIC REGURGITATION
![Page 7: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/7.jpg)
AORTIC REGURGITATION, THROUGH PLANE, MOTION-TRIGGERED 3 D VOLUMETRIC RENDERING
Schwitter
![Page 8: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/8.jpg)
– PHASE-CONTRAST CINE MRI - THROUGH PLANE
RF = 22%
Circulation 2009; 119: 468-478
V max = 3.37 m/s
ΔP max = 45 mmHg
AORTIC REGURGITATION, BICUSPID VALVE
![Page 9: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/9.jpg)
AORTIC REGURGITATION
REGURGITATION FRACTION (J Cardiovasc Magn Reson 2006)
MILD = RF <15%
MODERATE = RF 16-25%
MODERATE-SEVERE = RF 26-48%
SEVERE = RF > 48%
REGURGITATION ORIFICE AREA (ROA) (Heart 2008)
MODERATE-SEVERE = ROA >0.28 cm2
SEVERE = ROA > 0.48 cm2
![Page 10: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/10.jpg)
AORTIC ANGIOGRAPHY : ADDITIONAL INFORMATIONS
AORTIC DIAMETERS
![Page 11: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/11.jpg)
AORTIC ANGIOGRAPHY: ADDITIONAL INFORMATIONS
![Page 12: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/12.jpg)
Ventricular Function –
SSFP CINE MRI
CMR gold standard for RV and LV volumes and mass (Lancet 1985, Radiology 1990, 2005; J CMR 2003)
FU pre and post cardiac surgery
Regional wall motion analysisCourtesy of S. Pedretti H. Niguarda
![Page 13: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/13.jpg)
ADDITIONAL I NFORMATIONS: CORONARY ORIGIN AND COURSE
![Page 14: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/14.jpg)
MITRAL VALVE– SSFP CINE MRI
MITRAL SCALLOPS
A1A2
A3
P1P2
P3
Area = 2.4 cm2
![Page 15: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/15.jpg)
MITRAL VALVE – ANALYTIC EVALUATION WITH SSFP CINE MRI
Chan KMJ et at. JCMR 2008;10:61
![Page 16: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/16.jpg)
A2 – P2
A2 – P2
MITRAL VALVE – SSFP CINE MRI – PHASE CONTRAST MRI
![Page 17: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/17.jpg)
MITRAL REGURGITATION – SSFP CINE MRI
REGURGITATION FRACTION
RF = LVSV – FWAo / LVSV
RF = LVSV – RVSV / LVSV
RV = 52ml, RF = 44%
Circulation 2009; 119: 468-478
![Page 18: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/18.jpg)
ADDITIONAL INFORMATIONS – LATE ENHANCEMENT
![Page 19: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/19.jpg)
ADDITIONAL INFORMATIONS – LATE ENHANCEMENT
MITRAL PROLAPSE: papillary muscles late enhancement and major ventricular arrhythmias (JACC Cardiovascular Imaging 2008;1:294-303)
![Page 20: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/20.jpg)
MITRAL PROLAPSE: PAPILLARY MUSCLES FIBROSIS
![Page 21: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/21.jpg)
Ebstein’s Disease – SSFP CINE MRI
![Page 22: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/22.jpg)
TRICUSPID REGURGITATION – SSFP CINE MRI – PHASE CONTRAST
TRICUSPID REGURGITANT FRACTION
RF = RVSV – FWPo / RVSV
RF = RVSV – LVSV / RVSV
Circulation 2009; 119: 468-478
![Page 23: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/23.jpg)
PULMONARY VALVE – SSFP CINE MRI – PHASE CONTRAST
TETRALOGY OF FALLOT : PULMONARY REGURGITATION
![Page 24: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/24.jpg)
PULMONARY REGURGITATION – PHASE CONTRAST – THROUGH PLANE
RF = 51%
LV EDV = 66 ml
LV ESV = 19 ml
LVEF = 71%
RV EDV = 139 ml
RV ESV = 46 ml
RV EF = 63%
![Page 25: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/25.jpg)
ADDITIONAL INFORMATIONS - ANGIOGRAPHY
*
* RPALPA
LPA Stenosis – Left Lung hypoperfusion
![Page 26: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/26.jpg)
ADDITIONAL IN FORMATIONS – LATE ENHANCEMENT
LE as adverse marker of clinical
outcome in repaired Tetralogy
of Fallot
Circulation 2006; 113:405-413
![Page 27: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/27.jpg)
PHASE CONTRAST ALIASING: CHOOSING THE RIGHT VELOCITY
IN-PLANE THROUGH-PLANE
1,5 m/s
3,0 m/s
![Page 28: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/28.jpg)
![Page 29: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/29.jpg)
![Page 30: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/30.jpg)
![Page 31: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/31.jpg)
Velocity encoding interval sampling
Background correction
Non breath-hold acquisition for right-sided valves
Isocenter acquisition (FOV automatic positioning)
Correct through-plane positioning
Technical pitfalls
![Page 32: MRI for assessment of valvular heart disease: promises and](https://reader034.vdocument.in/reader034/viewer/2022042822/62696df71f47dc4f9e6d0162/html5/thumbnails/32.jpg)
Arrhythmias
Claustrophobia
Pace-maker
Cerebro-vascular clips
Severe chronic renal disease (GFR < 30 ml/min)
Clinical limitations